The company said, “We expect U.S. net revenue for the first quarter of 2026 to grow by approximately 25% over the fourth quarter of 2025 and expect net revenue for the second quarter of 2026 to grow by approximately 25% over the first quarter of 2026. International revenue is expected to follow a typical seasonal pattern.”
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NYXH:
- Is NYXH a Buy, Before Earnings?
- Nyxoah’s BREATHE Study: Post‑Approval Data Push for Genio Could Shape Sleep Apnea Market
- Inspire Medical jumps after KeyBanc says CMS ‘appears ready’ to add C-codes
- Nyxoah signs MoU with Sheikh Shakhbout Medical City
- Nyxoah Expands Belgian Manufacturing Hub to Support Global Growth in OSA Therapy